BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9616282)

  • 1. Ewing's sarcoma of the pelvis: changes over 25 years in treatment and results.
    Burgers JM; Oldenburger F; de Kraker J; van Bunningen BN; van der Eijken JW; Delemarre JF; Staalman CR; Voûte PA
    Eur J Cancer; 1997 Dec; 33(14):2360-7. PubMed ID: 9616282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
    Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I
    J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors.
    Pape H; Laws HJ; Burdach S; van Kaik B; Glag M; Gripp S; Wittkamp M; Jürgens H; Göbel U; Schmitt G
    Strahlenther Onkol; 1999 Oct; 175(10):484-7. PubMed ID: 10554642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?
    Albergo JI; Gaston CLL; Parry MC; Laitinen MK; Jeys LM; Tillman RM; Abudu AT; Grimer RJ
    Bone Joint J; 2018 Feb; 100-B(2):247-255. PubMed ID: 29437069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surgery and resection margins in the treatment of Ewing's sarcoma.
    Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
    Clin Orthop Relat Res; 2001 Nov; (392):394-9. PubMed ID: 11716413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
    Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
    Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery.
    Bacci G; Ferrari S; Longhi A; Versari M; Forni C; Donati D; Manfrini M; Trentani P; Barbieri E
    J Bone Joint Surg Br; 2003 Jan; 85(1):107-14. PubMed ID: 12585587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.
    Bacci G; Forni C; Longhi A; Ferrari S; Donati D; De Paolis M; Barbieri E; Pignotti E; Rosito P; Versari M
    Eur J Cancer; 2004 Jan; 40(1):73-83. PubMed ID: 14687792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing's sarcoma of the ribs. A report from the cooperative Ewing's sarcoma study.
    Ozaki T; Lindner N; Hoffmann C; Hillmann A; Rödl R; Blasius S; Link T; Winkelmann W; Jürgens H
    Eur J Cancer; 1995 Dec; 31A(13-14):2284-8. PubMed ID: 8652257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
    Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience.
    Smeland S; Wiebe T; Brosjö O; Böhling T; Alvegård TA
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):87-91. PubMed ID: 15188670
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ewing's sarcoma--report of 18 cases].
    Gu BH
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):452-4. PubMed ID: 2634546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing's tumour. A study of behaviour and treatment in forty-seven cases.
    Macintosh DJ; Price CH; Jeffree GM
    J Bone Joint Surg Br; 1975 Aug; 57(3):331-40. PubMed ID: 1057545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
    Elomaa I; Blomqvist CP; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård TA
    Eur J Cancer; 2000 May; 36(7):875-80. PubMed ID: 10785592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.
    Dramis A; Grimer RJ; Malizos K; Tillman RM; Jeys L; Carter LR
    Acta Orthop Belg; 2016 Aug; 82(2):216-221. PubMed ID: 27682283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.
    Laws HJ; Burdach S; van Kaick B; Engel B; Dirksen U; Körholz D; Pape H; Kahn T; Merck H; Schmitz M; Heyll A; Dockhorn-Dworniczak B; Jürgens H; Göbel U
    Strahlenther Onkol; 1999 Oct; 175(10):488-94. PubMed ID: 10554643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.